Ayurwin Pharma - Due diligence report

A 360° intelligence report on Ayurwin Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals…

2011-11-02 Bangalore, Karnataka Dissolved (Liquidated) Unlisted Active Non-Compliant
Share
Connect MCP
AP Ayurwin Pharma
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ayurwin Pharma — 360° Intelligence Report

Generated from MCA filings & public records
55/100
Trust Score
Moderate

Ayurwin Pharma is assessed as Moderate with a Trust Score of 55/100. Ayurwin Pharma is a private limited indian non-government company incorporated in 2011, operating in the Healthcare sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 28 Sep 2026 from the latest processed filings. Ayurwin Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
55/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 1 open (6.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Corporation Bank1 48.0 cr
Compliance Score: 5/100 Caution Indicated
  • Company status is "Dissolved (Liquidated)" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Flagged by authority: NCLT.
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
PONNATHAPURA BYREGOWDA SHIVAKUMARA 01234567 Director 01/04/2018 6 yrs Approved
PARVATHAKKAL RUDRESH SWETHA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • PONNATHAPURA BYREGOWDA SHIVAKUMARA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2015)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 45
Growth signals & trust indicators
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Operating for 14+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
Statutory filings appear overdue.
Adverse company status: Dissolved (Liquidated).
Compliance score is weak (5/100).
1 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence32/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment52/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 6.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 6 events
30 Sep 2015
Last AGM held
Annual general meeting
31 Mar 2015
Latest balance sheet
Filed with ROC
05 Mar 2015
Charge created
Corporation Bank - 6.00 cr
02 Nov 2011
Incorporated
Registered with Roc Bangalore
Director appointed
PONNATHAPURA BYREGOWDA SHIVAKUMARA (Director)
Director appointed
PARVATHAKKAL RUDRESH SWETHA (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2015 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Freedom Rubber Limited U99999PB1986PLC006660 Punjab, Punjab, India
Surya Containers Pvt Ltd U20230GJ1993PTC020196 Kalol, Gujarat, India
Shaktiman Cements And Packaging Industries Limited U26900HR2011PLC044154 Yamuna Nagar, Haryana, India
Rotoflow Polymers Private Limited U25209MH1996PTC101937 Aurangabad, Maharashtra, India
S I Precision Mould Private Limited U25201DL2004PTC125465 New Delhi, Delhi, India
Aegan Batteries Limited U24232KA2010PLC055616 Bengaluru, Karnataka, India
Asian Stainless Private Limited U27100GJ2011PTC065334 Ahmedabad, Gujarat, India
Rubberking Tyres India Private Limited U25110GJ1988PTC010340 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ayurwin Pharma before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ayurwin Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Ayurwin Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 55/100, distress signals and MSME payment-delay disclosures - know whether Ayurwin Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Ayurwin Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ayurwin Pharma an active company?

Ayurwin Pharma has MCA status “Dissolved (Liquidated)” with a compliance score of 5/100 (Caution Indicated).

Is Ayurwin Pharma financially healthy?

Ayurwin Pharma has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Ayurwin Pharma?

Its overall Trust Score is 55/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ayurwin Pharma?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Ayurwin Pharma have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Ayurwin Pharma up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Ayurwin Pharma?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.